Deciphera Pharmaceuticals Inc (DCPH)
25.45
+0.01
(+0.04%)
USD |
NASDAQ |
May 15, 15:29
Deciphera Pharmaceuticals Cash from Operations (Quarterly): -54.58M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -54.58M |
| December 31, 2023 | -28.81M |
| September 30, 2023 | -29.81M |
| June 30, 2023 | -38.63M |
| March 31, 2023 | -49.46M |
| December 31, 2022 | -35.16M |
| September 30, 2022 | -20.83M |
| June 30, 2022 | -45.52M |
| March 31, 2022 | -51.35M |
| December 31, 2021 | -67.18M |
| September 30, 2021 | -54.00M |
| June 30, 2021 | -51.97M |
| March 31, 2021 | -67.68M |
| December 31, 2020 | -49.13M |
| September 30, 2020 | -49.34M |
| Date | Value |
|---|---|
| June 30, 2020 | -60.84M |
| March 31, 2020 | -80.37M |
| December 31, 2019 | -55.83M |
| September 30, 2019 | -23.19M |
| June 30, 2019 | -37.27M |
| March 31, 2019 | -33.01M |
| December 31, 2018 | -26.87M |
| September 30, 2018 | -24.93M |
| June 30, 2018 | -18.29M |
| March 31, 2018 | -16.69M |
| December 31, 2017 | -12.75M |
| September 30, 2017 | -8.866M |
| June 30, 2017 | -7.666M |
| March 31, 2017 | -7.417M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-80.37M
Minimum
Mar 2020
-20.83M
Maximum
Sep 2022
-47.55M
Average
-49.40M
Median
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.834B |
| Dynavax Technologies Corp | -16.68M |
| Gilead Sciences Inc | 2.219B |
| Esperion Therapeutics Inc | 53.83M |
| SINTX Technologies Inc | -3.128M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 62.63M |
| Cash from Financing (Quarterly) | 0.522M |
| Free Cash Flow | -152.39M |
| Free Cash Flow Per Share (Quarterly) | -0.6263 |
| Free Cash Flow to Equity (Quarterly) | -54.73M |
| Free Cash Flow Yield | -6.94% |